AICDA and B-cell chronic lymphocytic leukemia: Instead, it may be beneficial to investigate how to selectively enhance the expression levels or activity of AID in CLL cells as a targeted therapeutic approach in driving CLL towards the indolent IgHV-mutated phenotype.